Commerce Department, International Trade Administration Briefing 2026-06-02
Estimated reading time: 5 minutes
1. N-Cyclohexylbenzothiazole-2-Sulfenamide from the People’s Republic of China: Initiation of Countervailing Duty Investigation
Sub: Commerce Department, International Trade Administration
2. N-Cyclohexylbenzothiazole-2-Sulfenamide From the People’s Republic of China: Initiation of Less-Than-Fair-Value Investigation
Sub: Commerce Department, International Trade Administration
3. Agency Information Collection Activities; Submission to the Office of Management and Budget (OMB) for Review and Approval; Comment Request; Applications for Inclusion on the Lists of Arbitrators Under the Data Privacy Framework Program
Sub: Commerce Department, International Trade Administration
4. Certain Activated Carbon From the People’s Republic of China: Amended Final Results of Antidumping Duty Administrative Review; 2023-2024
Sub: Commerce Department, International Trade Administration
Content: The U.S. Department of Commerce (Commerce) is amending its final results of the administrative review of the antidumping duty (AD) order on certain activated carbon from the People's Republic of China (China) to correct ministerial errors. The period of review (POR), April 1, 2023, through March 31, 2024.
5. Initiation of Antidumping and Countervailing Duty Administrative Reviews
Sub: Commerce Department, International Trade Administration
Content: The U.S. Department of Commerce (Commerce) has received requests to conduct administrative reviews of various antidumping duty (AD) and countervailing duty (CVD) orders with April anniversary dates. In accordance with Commerce's regulations, we are initiating those administrative reviews.
6. Antidumping or Countervailing Duty Order, Finding, or Suspended Investigation; Opportunity To Request Administrative Review and Join Annual Inquiry Service List; Note Regarding Format of Review Requests
Sub: Commerce Department, International Trade Administration
Legal Disclaimer
This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.


